Public announcement
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
Hot of the press and we are excited: The EQIPD framework for rigor in the design, conduct, analysis, and documentation of animal experiments. It defines the demands for five domains researchers should be aware of and the needs for them in research design and publications.
On October 10, 2022, #EQIPD will lead a discussion on how to help funders and grant applicants align on research rigor expectations and avoid funding of research of unknown quality. Objectives of the meeting are to: Review lessons learned from the US and German publicly funded programs that focused directly or indirectly on decision-enabling research…
The Guarantors of EQIPD (GoEQIPD) is a not-for-profit society established to oversee the implementation of the EQIPD Quality System (QS). We are seeking proposals from organisations who wish to work with us in providing mentoring and accreditation to laboratories wishing to meet EQIPD QS standards. Read about the EQIPD QS in our eLife publication Read…
Have you been scorched by this year’s summer heat all over Europe already? Here are more hot summer-news from the EQIPD project: Find out more about the flaming-fresh series of 9 “EQIPD video blasts’’, our next Summer School, the EQIPD session at the annual ECNP Congress, and about the kick-off of implementing the new Quality…
In the newest edition of the newsletter, find out more about the highlights of the EQIPD General Assembly meeting, the new project collaborations, CAMARADES winning the BNA’s ‘Credibility Prize’ and details on the 34th ECNP congress. Read the Newsletter here.
EQIPD and our efforts to ” Unclog pipeline for new medicines” is mentioned in form of a brief article in NATURE CORRESPONDENCE. Click here to get to the article!